A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming-Reference-Cited by-同舟云学术

A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming

Published:2022-10-15 Issue:47 Volume:41 Page:5076-5091
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Yousefi Hassan,Khosla Maninder,Lauterboeck Lothar,Okpechi Samuel C.,Worthylake David,Garai Jone,Zabaleta Jovanny,Guidry Jessie,Zarandi Mohammad Amin,Wyczechowska Dorota,Jayawickramarajah Janarthanan,Yang Qinglin,Kissil Joseph,Alahari Suresh K.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02497-2.pdf

Reference126 articles.

1. Yin L, Duan J-J, Bian X-W, Yu S-C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 2020;22:61.

2. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N. Engl J Med. 2010;363:1938–48.

3. Marra A, Trapani D, Viale G, Criscitiello C, Curigliano G. Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies. NPJ Breast Cancer. 2020;6:1–16.

4. Bianchini G, Balko JM, Mayer IA, Sanders ME, Gianni L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674–90.

5. Arumugam A, Subramani R, Nandy SB, Terreros D, Dwivedi AK, Saltzstein E, et al. Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2. Exp Mol Med. 2019;51:1–13.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer resistance and metastasis are maintained through oxidative phosphorylation;Cancer Letters;2024-04

2. Proteomics Analysis of Polyphyllin D-Treated Triple-Negative Breast Cancer Cells Reveal the Anticancer Mechanisms of Polyphyllin D;Applied Biochemistry and Biotechnology;2023-08-25

3. Ir(III) Compounds Containing a Terdentate Ligand Are Potent Inhibitors of Proliferation and Effective Antimetastatic Agents in Aggressive Triple-Negative Breast Cancer Cells;Journal of Medicinal Chemistry;2023-07-06

4. Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming;Oncogene;2023-02-09

5. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer;Molecules;2023-01-11